LONG 5x Stock Opportunity

Outlier Capital · Outlier Capital · April 24, 2026 at 12:31 · ⏱ 2 min read  | Read on Substack ↗
Summary
Outlier Capital highlights Trio-Tech ($TRT) as a deep value play in AI semiconductor testing, citing 82% YoY revenue growth and a low 2.2x P/S ratio versus peers like Aehr Test Systems. The author is beginning to build a long position via dollar-cost averaging to manage micro-cap volatility, expecting a re-rating as the AI tailwind materializes on the income statement.
  • •$TRT has a market cap of $110M, TTM revenue of $49M, and 82% YoY growth, trading at just 2.2x P/S.
  • •The valuation gap versus peer $AEHR (historically ~60x forward P/S) is described as a 'canyon.'
  • •The author is beginning to build a long position slowly via dollar-cost averaging to mitigate micro-cap volatility.
  • •The thesis is that TRT's legacy burn-in board business is now mission-critical for next-gen AI GPUs, driving a potential re-rating.
Read time 2 min
Length 2,182 chars
Category finance
Trade Ideas
Outlier Capital Substack author, Outlier Capital
The author believes TRT is deeply undervalued given its 82% YoY growth and low P/S, and is buying shares gradually to manage micro-cap volatility.
TRT MED
More from Outlier Capital
Portfolio Update: I’m Making Two Moves Today
Apr 23, 22:00
America Just Lit the Fuse on a Defense-and-Grid Supercycle — 5 Stocks the Market Still Doesn’t Fully Get
Apr 23, 09:39
LONG +3x Stock Opportunity
Apr 22, 12:09
LPKF Laser ($LPK): The Best Small-Cap Way to Play the Glass Packaging Supercycle?
Apr 22, 09:05
Small 100x Stock Portfolio — Third Week of April 2026 Update
Apr 21, 18:21

This newsletter, published April 24, 2026, features Outlier Capital discussing TRT. 1 trade idea extracted by AI with direction and confidence scoring.

Speakers: Outlier Capital  · Tickers: TRT